Paeds SAQs · neurology-neurodisability-and-neuromuscular
Movement disorders, dystonia and chorea: SAQ
Short-answer questions on paediatric movement disorders covering the classification of hyperkinetic movements, the status dystonicus emergency and its escalation ladder, the acute dystonic reaction and its reversal, the empiric levodopa trial in dopa-responsive dystonia, Sydenham chorea as a major Jones criterion with penicillin prophylaxis, Wilson disease screening, and the dystonic cerebral palsy management ladder.
On this page & tools
Target exams
This girl presents the classic picture of Sydenham chorea, the neurologic manifestation of acute rheumatic fever, which follows group A streptococcal infection by weeks to months and is a major Jones criterion. The asymmetric flowing movements, the emotional lability and obsessional behaviour, the hypotonia, the motor impersistence with a milkmaid grip and darting tongue, and the preceding sore throat fit the diagnosis, and the echocardiographic mitral regurgitation confirms rheumatic carditis. [4]
Question 1 (10 marks)
Define the movement disorder this girl shows, outline your diagnostic workup, and describe your immediate and long-term management. [4]
This girl has chorea, defined as flowing, unpredictable, semi-purposeful movements that the child cannot suppress, with motor impersistence shown by the milkmaid grip and the darting tongue. The diagnosis is Sydenham chorea, which is a major criterion of acute rheumatic fever following group A streptococcal infection. [4]
My diagnostic workup confirms recent streptococcal infection and assesses the heart. I send anti-streptolysin O and anti-DNase B titres and a throat swab, request an echocardiogram and electrocardiogram because rheumatic carditis may be clinically silent, and arrange a basic infection and autoimmune screen. An EEG is sent only if there is doubt about whether the movements represent a seizure. The diagnosis is clinical, based on the Jones criteria, and the antibody results support rather than establish it. [4]
My immediate management is supportive, with a calm environment, rest, and attention to hydration, safety, and the emotional distress that accompanies the illness. For moderate or severe chorea I add a symptomatic drug such as valproate, carbamazepine, or a neuroleptic, titrated to control the movements. For severe or refractory chorea, the evidence supports a short course of corticosteroids. I do not use metoclopramide, because dopamine-blocking antiemetics can worsen movement disorders and precipitate an acute dystonic reaction. [5]
My long-term management is secondary penicillin prophylaxis to prevent recurrence of acute rheumatic fever and to protect the heart. I start intramuscular benzathine penicillin G every four weeks, at a dose of 600,000 units for a child weighing 27 kilograms or less and 1,200,000 units for a heavier child. This girl weighs 32 kilograms, so she receives 1,200,000 units every four weeks, continued into early adulthood per the local rheumatic fever guideline. I arrange paediatric cardiology follow-up for surveillance of the rheumatic heart disease, and I address the cultural and remote-access needs of her family with an Aboriginal health worker and a clear retrieval and follow-up pathway. [4]
You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship atlas.
References7Show ledgerHide ledger
- [1]Albanese A, Bhatia K, Bressman SB, et al Phenomenology and classification of dystonia: a consensus update. Mov Disord, 2013.PMID 23649720
- [2]Sanger TD Pediatric movement disorders. Curr Opin Neurol, 2003.PMID 12869814
- [4]Gewitz MH, Baltimore RS, Tani LY, et al Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association. Circulation, 2015.PMID 25908771
- [5]Dean SL, Singer HS Treatment of Sydenham's Chorea: A Review of the Current Evidence. Tremor Other Hyperkinet Mov (N Y), 2017.PMID 28589057
- [6]Allen NM, Lin JP, Lynch T, King MD Status dystonicus: a practice guide. Dev Med Child Neurol, 2014.PMID 24304390
- [7]Vogt LM, Yang K, Tse G, et al Recommendations for the Management of Initial and Refractory Pediatric Status Dystonicus. Mov Disord, 2024.PMID 38619077
- [12]Segawa M Dopa-responsive dystonia. Handb Clin Neurol, 2011.PMID 21496606